| A LMWH preparation which is similar to other LMWH preparations.
| Composition : | 3075 IU /0.3 ml, 4100 IU/0.4ml, 6150 IU/0.6 ml | | Indications : | Unstable angina and non Q-wave myocardial infarction. Deep vein thrombosis and as preventive agent for clotting in extracorporeal system in haemodialysis. | | Contraindications : | Cerebral hemorrhage, ulcer in GIT., coagulation disorders, septic endocarditis. | | Adverse Effects : | Bleeding, subcutaneous haematoma and thrombocytopenia. | | Dosage : | See the insert | | Purity : | Not less than 99%. |
|
 |
© Health Biotech Limited. All Rights Reserved (Terms of Use)
